Biopharmaceutical compositions
US11274148B2 · kind B2 · utility
3Cited by
18References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2021 |
| Grant date | Mar 15, 2022 |
| Priority date | — |
| Expiry date | Jul 12, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions, for treating interleukin 5 (IL-5) mediated diseases, and related methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.